These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 16541184)
1. Dronedarone: a new antiarrhythmic agent. Zareba KM Drugs Today (Barc); 2006 Feb; 42(2):75-86. PubMed ID: 16541184 [TBL] [Abstract][Full Text] [Related]
2. Dronedarone: an amiodarone analog for the treatment of atrial fibrillation and atrial flutter. Dale KM; White CM Ann Pharmacother; 2007 Apr; 41(4):599-605. PubMed ID: 17389667 [TBL] [Abstract][Full Text] [Related]
9. Dronedarone: a review of characteristics and clinical data. Baroletti S; Catella J; Ehle M; Cheng JW Crit Pathw Cardiol; 2010 Jun; 9(2):94-101. PubMed ID: 20520217 [TBL] [Abstract][Full Text] [Related]
10. Dronedarone: a new antiarrhythmic agent for the treatment of atrial fibrillation. Garcia D; Cheng-Lai A Cardiol Rev; 2009; 17(5):230-4. PubMed ID: 19690474 [TBL] [Abstract][Full Text] [Related]
11. Dronedarone for the treatment of atrial fibrillation and atrial flutter. Maund E; McKenna C; Sarowar M; Fox D; Stevenson M; Pepper C; Palmer S; Woolacott N Health Technol Assess; 2010 Oct; 14(Suppl. 2):55-62. PubMed ID: 21047492 [TBL] [Abstract][Full Text] [Related]
12. Dronedarone: a promising alternative for the management of atrial fibrillation. Yalta K; Turgut OO; Yilmaz MB; Yilmaz A; Tandogan I Cardiovasc Drugs Ther; 2009 Oct; 23(5):385-93. PubMed ID: 19669399 [TBL] [Abstract][Full Text] [Related]
13. Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy. Wolbrette D; Gonzalez M; Samii S; Banchs J; Penny-Peterson E; Naccarelli G Vasc Health Risk Manag; 2010 Aug; 6():517-23. PubMed ID: 20730068 [TBL] [Abstract][Full Text] [Related]
14. A new agent for atrial fibrillation: electrophysiological properties of dronedarone. Singh BN; Cingolani E J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):6S-14S. PubMed ID: 21098415 [TBL] [Abstract][Full Text] [Related]
15. Dronedarone: an emerging therapy for atrial fibrillation. Rosei EA; Salvetti M Ther Adv Cardiovasc Dis; 2010 Jun; 4(3):155-64. PubMed ID: 20418270 [TBL] [Abstract][Full Text] [Related]
16. A review of the appropriate and inappropriate use of dronedarone: lessons learned from controlled studies and regulatory submission. Naccarelli GV; Wolbrette DL; Samii S; Banchs JE; Penny-Peterson E; Gonzalez MD J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4 Suppl):24S-30S. PubMed ID: 21098416 [TBL] [Abstract][Full Text] [Related]
17. The novel antiarrhythmic drug dronedarone: comparison with amiodarone. Kathofer S; Thomas D; Karle CA Cardiovasc Drug Rev; 2005; 23(3):217-30. PubMed ID: 16252015 [TBL] [Abstract][Full Text] [Related]
18. [Clinical profile of the new antiarrhythmic drug dronedarone]. Schmitt J; Lewalter T; Pittrow D; Duray G; Goette A; Brachmann J; Hohnloser SH Dtsch Med Wochenschr; 2010 Mar; 135 Suppl 2():S38-42. PubMed ID: 20221977 [TBL] [Abstract][Full Text] [Related]
19. Dronedarone or amiodarone for rhythm control for atrial fibrillation: implications from the DIONYSOS study. Pamukcu B; Lip GY Expert Opin Pharmacother; 2010 Dec; 11(17):2775-8. PubMed ID: 21050033 [TBL] [Abstract][Full Text] [Related]
20. Dronedarone for atrial fibrillation therapy. Marzocchi M; Lombardi F Expert Rev Cardiovasc Ther; 2011 Jun; 9(6):675-83. PubMed ID: 21714598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]